Introduction Regulatory requirements for PLGA excipient qualification have become stricter under the US FDA, EMA, and global ICH frameworks. Because […]
Summary Introduction: The Science of Custom PLGA Release Control At ResolveMass Laboratories Inc., Custom PLGA Release Control represents a full
Introduction This PLGA Microsphere Case Study provides a detailed look at the formulation design and process development behind a generic
Summary (Key Takeaways) Introduction Scaling PLGA (Poly(lactic-co-glycolic acid)) from small batches to multi-kg output is a major milestone for any
Introduction: Why PLGA Microparticles Are Reshaping Oncology Formulation In modern cancer treatment, PLGA Oncology Formulation platforms are transforming how drugs
INTRODUCTION End Capped PLGA plays a fundamental role in the stability, degradation rate, and drug interaction behavior of biodegradable formulations.
End-Capped vs Acid-Terminated PLGA — Impact on Stability & Drug Interaction Read More »
🔍 Summary of Key Takeaways Introduction: The Core Challenge of PLGA Microencapsulation Scale Up Scaling up a PLGA microencapsulation process
INTRODUCTION Pharmaceutical scientists rely heavily on PLGA PDI Pharmaceutical characteristics because the Polydispersity Index determines the consistency and reliability of
Understanding Polydispersity Index (PDI) in Pharmaceutical Grade PLGA Read More »
Quick Summary Introduction Achieving strong PLGA Formulation Stability is one of the biggest challenges in developing controlled-release injectable products. Although
Summary — Key Takeaways Introduction Achieving a stable and uniform solution of PLGA (Poly(lactic-co-glycolic acid)) is one of the most
